Regeneron's antibody therapy cuts deaths among some hospitalised Covid-19 patients -study

The therapy, REGEN-COV, has been granted emergency use authorisation for people with mild-to-moderate Covid-19 in the United States, but results from the RECOVERY trial provide the clearest...